Evidence map›Paper›PMID 41611882›Full record

ArticleScientific reports2026

Computational identification and mechanistic characterization of natural product binders targeting the PDE6D prenyl binding tunnel.

Mohammed Merae Alshahrani

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohammed Merae AlshahraniDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, 1988, 61441, Najran, Saudi Arabia. mmalshahrani@nu.edu.sa.ORCID http://orcid.org/0000-0002-9387-5492

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RAS oncogenesis remains a significant clinical challenge due to the difficulty of directly targeting RAS proteins. PDE6D, a prenyl-binding chaperone involved in the RAS membrane trafficking pathway, represents an indirect yet tractable target whose modulation has been proposed to influence RAS localization and signaling. This study employed a multiscale structure-based in silico workflow to identify natural compounds with putative binding potential toward the prenyl-binding tunnel of PDE6D. A curated natural product library was screened using molecular docking, followed by density functional theory–based geometry optimization. Additional 500 ns molecular dynamics simulations were then used to analyze the stability of binding and the overall conformational behavior of the most promising complexes. Further PCA and free energy landscape mapping highlighted distinct low-energy conformational states adopting unique structural transitions, where the MolPort-039-052-621 complex presented the most compact and well-defined low-energy basin. In that respect, superimposing free energy minima with the respective initial docked poses demonstrated minimal structural deviation from the binding orientation during dynamic evolution. Finally, QM/MM calculations qualitatively described the electronic stabilization of the ligands within the PDE6D environment. The present study identifies natural compounds with computationally favourable tunnel-binding characteristics and provides mechanistic insights that may guide future experimental validation.

Indexed as

Molecular docking and simulationsNatural product inhibitorsOncogenic RAS signaling disruptionPDE6D inhibitionRAS oncogenesis

Identifiers

PMID41611882
PMCPMC12909305

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.